CloroxPro Blog
    PathogensHealthcare

Emerging Pathogens in Healthcare Settings

Image

The 21st century world is being impacted by emerging pathogens on an unprecedented scale.¹ Not only are we experiencing diagnostic and treatment challenges that come with emerging pathogens, but there can also be implications for cleaning and disinfecting against a novel pathogen.

Where to start?

It is imperative to select appropriate disinfecting products when dealing with emerging pathogens. But when a pathogen is novel, it is not likely that a disinfectant on the market will have claims against it — at least not right away — and adding new claims to an existing product does not happen overnight. It takes about a year to get new claims approved by the US Environmental Protection Agency (EPA).

So, how do you identify an effective product? The first step is to see if any specific policies, requirements, or resources have been issued in relation to the novel pathogen(s) in question. For example, the EPA's Emerging Viral Pathogen Policy and  (e.g., List N, List K, List Q) can be used to find appropriate products (Image 1). It is important to note that the EPA’s Emerging Viral Pathogen policy only applies to viruses. It does not apply to emerging bacteria, fungi, or other pathogens.

Image

Image 1: EPA's Emerging Viral Pathogen (EVP) Policy and List Q

Understanding EPA’s List Q

List Q is unique from the other EPA Lists because it does not target a specific pathogen. With this List, the user searches for eligible products for use against an emerging pathogen by selecting the appropriate tier based on virus type.

To navigate List Q, there are a few things you need to know about the emerging pathogen including if it is:

  • An enveloped virus (tier 1- the easiest of the 3 types to kill),
  • A large non-enveloped virus (tier 2), or a
  • A small non-enveloped virus (tier 3 – the hardest of the virus types to kill).

Lastly, it is important to understand that because a given product from List Q meets the criteria for use against one emerging virus (e.g., Mpox), it does not mean this product will be effective against any future emerging viruses. It is designed to be used on a pathogen-by-pathogen basis.2

In situations when guidance like the EPAs Emerging Viral Pathogen policy is not activated, I recommend using a sporicidal, like bleach, because it is broad-spectrum against hard-to-kill pathogens (see CloroxPro “Bleach is B.E.S.T.” blog). Please note — some disinfecting chemistries may be more effective than others against a given pathogen. For example, disinfectants with quaternary ammonium compounds (e.g., “quats”) as the only active ingredient have not been found to be effective against Candida auris.3

Control and contain

Beyond identifying the correct product to use, it is also imperative to identify a process for managing an emerging pathogen. For example, protocols should include the personal protective equipment (PPE) to be worn to enter the room, cleaning frequency, and the appropriate disinfectant to be used. Cleaning and disinfecting protocols may differ by pathogen, so it is also important that staff are educated and trained to safely and effectively clean and disinfect against novel pathogens.

Additional Resources

In addition to the EPA's Emerging Viral Pathogen Policy and the EPA Disinfectant Lists, other organizations have published helpful resources you can use to help you identify the appropriate disinfecting products to use and implement a process for managing an emerging pathogen. The Centers for Disease Control and Prevention (CDC) guidance, the National Emerging Special Pathogens Training and Education Center (NETEC) is another great resource for guidelines. You can also check out the CloroxPro HealthyClean online learning platform for more training and education opportunities for yourself or your staff.

Share this article

About the Author

Profile image of Doe Kley, RN, MPH, CIC, LTC-CIP, T-CHEST
Infection Prevention Fellow, Clorox Healthcare
Doe Kley is the Infection Prevention Fellow within Clorox Healthcare’s Clinical and Scientific Affairs team and is passionate about identifying problems and finding solutions to the many challenges faced in infection prevention. She develops tools and solutions based on her nearly 20 years of clinical expertise.  Much of her expertise in acute care infection prevention comes from working in large healthcare systems including Intermountain Healthcare and Kaiser Permanente. Doe is a registered nurse and received her Master of Public Health from the University of Nevada, Reno, as well as a Bachelor of Microbiology from Weber State University. She taught an infection control course for the Ohio State University (OSU) from 2019 to 2022 and is also dual board certified in infection prevention and epidemiology in both acute and long-term care. Additionally, Doe is certified to train EVS through the Association for the Healthcare Environment (AHE) and is currently a member of AHE, the Association for Professionals in Infection Control & Epidemiology (APIC), the Association of Perioperative Registered Nurses (AORN) and the Society for Healthcare Epidemiology of America (SHEA). Doe is active on several committees including the Test Committee for the Certification Board of Infection Control & Epidemiology (CBIC) and the Advisory Council for the Pearce Foundation Environmental Services Optimization Playbook (EvSOP). She also served on the Board of Directors for the California APIC Coordinating Council (CACC) in 2022.

References

  1. Ambat A, Vyas N. Assessment and preparedness against emerging infectious disease among private hospitals in a district of South India. Open Access: Med J Armed Forces India [internet]. 2022;78(1):42-46.
  2. US Environmental Protection Agency. Disinfectants for Emerging Viral Pathogens (EVPs): List Q [Internet]. [cited 2023 Aug 14]. Available from https://www.epa.gov/pesticide-registration/disinfectants-emerging-viral-pathogens-evps-list-q
  3. Centers for Disease Control and Prevention. Infection Prevention and Control for Candida auris [Internet]. [cited 2023 Aug 14]. Available from https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html